Novozymes As B Stock Technical Analysis
| NVZMF Stock | USD 64.13 4.72 7.94% |
As of the 15th of February 2026, Novozymes secures the Downside Deviation of 2.93, risk adjusted performance of 0.0328, and Mean Deviation of 1.94. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novozymes AS B, as well as the relationship between them. Please verify Novozymes AS B jensen alpha and downside variance to decide if Novozymes AS B is priced some-what accurately, providing market reflects its recent price of 64.13 per share. Given that Novozymes AS B has jensen alpha of 0.0551, we recommend you to check Novozymes's last-minute market performance to make sure the company can sustain itself at a future point.
Novozymes Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Novozymes, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NovozymesNovozymes |
Novozymes 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novozymes' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novozymes.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Novozymes on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Novozymes AS B or generate 0.0% return on investment in Novozymes over 90 days. Novozymes is related to or competes with Symrise Ag, Givaudan, Sika AG, Sika AG, Akzo Nobel, LAir Liquide, and Akzo Nobel. Novozymes AS produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, N... More
Novozymes Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novozymes' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novozymes AS B upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.93 | |||
| Information Ratio | 0.0067 | |||
| Maximum Drawdown | 13.2 | |||
| Value At Risk | (4.87) | |||
| Potential Upside | 5.41 |
Novozymes Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novozymes' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novozymes' standard deviation. In reality, there are many statistical measures that can use Novozymes historical prices to predict the future Novozymes' volatility.| Risk Adjusted Performance | 0.0328 | |||
| Jensen Alpha | 0.0551 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0064 | |||
| Treynor Ratio | 0.2001 |
Novozymes February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0328 | |||
| Market Risk Adjusted Performance | 0.2101 | |||
| Mean Deviation | 1.94 | |||
| Semi Deviation | 2.27 | |||
| Downside Deviation | 2.93 | |||
| Coefficient Of Variation | 3139.94 | |||
| Standard Deviation | 2.78 | |||
| Variance | 7.74 | |||
| Information Ratio | 0.0067 | |||
| Jensen Alpha | 0.0551 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0064 | |||
| Treynor Ratio | 0.2001 | |||
| Maximum Drawdown | 13.2 | |||
| Value At Risk | (4.87) | |||
| Potential Upside | 5.41 | |||
| Downside Variance | 8.59 | |||
| Semi Variance | 5.15 | |||
| Expected Short fall | (2.76) | |||
| Skewness | 0.3296 | |||
| Kurtosis | 0.8899 |
Novozymes AS B Backtested Returns
At this point, Novozymes is very steady. Novozymes AS B has Sharpe Ratio of 0.0331, which conveys that the firm had a 0.0331 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Novozymes, which you can use to evaluate the volatility of the firm. Please verify Novozymes' Mean Deviation of 1.94, risk adjusted performance of 0.0328, and Downside Deviation of 2.93 to check out if the risk estimate we provide is consistent with the expected return of 0.0914%. Novozymes has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.39, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Novozymes' returns are expected to increase less than the market. However, during the bear market, the loss of holding Novozymes is expected to be smaller as well. Novozymes AS B right now secures a risk of 2.77%. Please verify Novozymes AS B downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Novozymes AS B will be following its current price movements.
Auto-correlation | 0.06 |
Virtually no predictability
Novozymes AS B has virtually no predictability. Overlapping area represents the amount of predictability between Novozymes time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novozymes AS B price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Novozymes price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 4.32 |
Novozymes technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Novozymes AS B Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Novozymes AS B across different markets.
About Novozymes Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Novozymes AS B on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Novozymes AS B based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Novozymes AS B price pattern first instead of the macroeconomic environment surrounding Novozymes AS B. By analyzing Novozymes's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Novozymes's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Novozymes specific price patterns or momentum indicators. Please read more on our technical analysis page.
Novozymes February 15, 2026 Technical Indicators
Most technical analysis of Novozymes help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Novozymes from various momentum indicators to cycle indicators. When you analyze Novozymes charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0328 | |||
| Market Risk Adjusted Performance | 0.2101 | |||
| Mean Deviation | 1.94 | |||
| Semi Deviation | 2.27 | |||
| Downside Deviation | 2.93 | |||
| Coefficient Of Variation | 3139.94 | |||
| Standard Deviation | 2.78 | |||
| Variance | 7.74 | |||
| Information Ratio | 0.0067 | |||
| Jensen Alpha | 0.0551 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0064 | |||
| Treynor Ratio | 0.2001 | |||
| Maximum Drawdown | 13.2 | |||
| Value At Risk | (4.87) | |||
| Potential Upside | 5.41 | |||
| Downside Variance | 8.59 | |||
| Semi Variance | 5.15 | |||
| Expected Short fall | (2.76) | |||
| Skewness | 0.3296 | |||
| Kurtosis | 0.8899 |
Novozymes February 15, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Novozymes stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | Huge | ||
| Rate Of Daily Change | 1.08 | ||
| Day Median Price | 64.13 | ||
| Day Typical Price | 64.13 | ||
| Price Action Indicator | 2.36 |
Complementary Tools for Novozymes Pink Sheet analysis
When running Novozymes' price analysis, check to measure Novozymes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novozymes is operating at the current time. Most of Novozymes' value examination focuses on studying past and present price action to predict the probability of Novozymes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novozymes' price. Additionally, you may evaluate how the addition of Novozymes to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |